Steffen Schmitz-Valckenberg, MD, discusses how optical coherence tomography-based models may enable rapid, noninvasive assessment of functional loss in GA at Angiogenesis 2026.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of its new HRD-RNA algorithm. This next-generation model ...

Creation of an end-to-end antibody engine: rapid discovery paired with physiologically relevant translational assays to confirm MoA early and de-risk IND readiness.Motherwell, Scotland, [17] February ...

QuantalX combined transcranial magnetic stimulation and EEG technology in its first-of-its-kind brain network function ...

An overview of the principles and advantages of functional ultrasound imaging for brain and neuropharmacology research.

Enterprise Ireland-backed platform connects its 1,000+ analytical Excel functions to Claude, ChatGPT, and leading AI tools MarketXLS Limited Image GALWAY, Ireland, Feb. 18, 2026 (GLOBE NEWSWIRE) -- As ...

FORT LAUDERDALE, FL - February 17, 2026 - PRESSADVANTAGE - A newly released educational resource from Grace Point ...

The reduction in depression and anxiety symptoms 3 months after completing ten AMHSP sessions indicates a slow but meaningful benefit of the programme and supports the potential of a low-intensity, ...

About Legacy Foot & Ankle Legacy Foot & Ankle is a podiatry practice focused on comprehensive foot and ankle care. Under the leadership of Dr. Joe Aoun, DPM, the clinic provides personalized treatment ...

Tempus AI TEM rose on Wednesday after the company unveiled its new HRD-RNA algorithm, an AI-driven tool designed to improve detection of homologous recombination deficiency (HRD) in tumors. The ...